81 related articles for article (PubMed ID: 17090524)
1. New potential ligand-receptor signaling loops in ovarian cancer identified in multiple gene expression studies.
Castellano G; Reid JF; Alberti P; Carcangiu ML; Tomassetti A; Canevari S
Cancer Res; 2006 Nov; 66(22):10709-19. PubMed ID: 17090524
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
[TBL] [Abstract][Full Text] [Related]
3. Association of metastin/a G-protein-coupled receptor signaling and Down syndrome critical region 1 in epithelial ovarian cancer.
Hata K; Watanabe Y; Nakai H; Minami T; Ohsaki H; Hirakawa E; Hoshiai H
Anticancer Res; 2009 Feb; 29(2):617-23. PubMed ID: 19331211
[TBL] [Abstract][Full Text] [Related]
4. IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer.
Spentzos D; Cannistra SA; Grall F; Levine DA; Pillay K; Libermann TA; Mantzoros CS
Endocr Relat Cancer; 2007 Sep; 14(3):781-90. PubMed ID: 17914107
[TBL] [Abstract][Full Text] [Related]
5. The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma.
Wu Q; Suo Z; Kristensen GB; Baekelandt M; Nesland JM
Gynecol Oncol; 2006 Jul; 102(1):15-21. PubMed ID: 16499955
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
Bagnato A; Rosanò L
Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
[TBL] [Abstract][Full Text] [Related]
8. Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer.
Hata K; Dhar DK; Watanabe Y; Nakai H; Hoshiai H
Eur J Cancer; 2007 Jun; 43(9):1452-9. PubMed ID: 17442564
[TBL] [Abstract][Full Text] [Related]
9. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
[TBL] [Abstract][Full Text] [Related]
10. Gene expression meta-analysis identifies chromosomal regions involved in ovarian cancer survival.
Thomassen M; Jochumsen KM; Mogensen O; Tan Q; Kruse TA
Genes Chromosomes Cancer; 2009 Aug; 48(8):711-24. PubMed ID: 19441089
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas.
Li AJ; Scoles DR; Armstrong KU; Karlan BY
Gynecol Oncol; 2008 May; 109(2):220-5. PubMed ID: 18374401
[TBL] [Abstract][Full Text] [Related]
12. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.
Grisaru D; Hauspy J; Prasad M; Albert M; Murphy KJ; Covens A; Macgregor PF; Rosen B
Oncol Rep; 2007 Dec; 18(6):1347-56. PubMed ID: 17982616
[TBL] [Abstract][Full Text] [Related]
13. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
Wang P; Wu X; Chen W; Liu J; Wang X
Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
[TBL] [Abstract][Full Text] [Related]
14. [Expression of phosphorylated protein kinase B and PTEN protein in ovarian epithelial cancer].
Qiao YH; Cheng J; Guo RX
Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):325-9. PubMed ID: 17673045
[TBL] [Abstract][Full Text] [Related]
15. Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance.
Connor JP; Felder M
Gynecol Oncol; 2008 Nov; 111(2):330-5. PubMed ID: 18723214
[TBL] [Abstract][Full Text] [Related]
16. Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer.
Wilkinson SJ; Kucukmetin A; Cross P; Darby S; Gnanapragasam VJ; Calvert AH; Robson CN; Edmondson RJ
Hum Pathol; 2008 Aug; 39(8):1197-204. PubMed ID: 18495208
[TBL] [Abstract][Full Text] [Related]
17. [Expression of AIB1 protein in epithelial ovarian cancer cells and its impact on apoptosis].
Han XY; Chen Y; Hou MM; Zhang J; Yang KX; Chen YY; Qie MR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):619-22, 634. PubMed ID: 18798508
[TBL] [Abstract][Full Text] [Related]
18. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
Lu L; Katsaros D; Wiley A; de la Longrais IA; Puopolo M; Yu H
Cancer Invest; 2008 Mar; 26(2):185-92. PubMed ID: 18259951
[TBL] [Abstract][Full Text] [Related]
19. Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1.
Rody A; Holtrich U; Gaetje R; Gehrmann M; Engels K; von Minckwitz G; Loibl S; Diallo-Danebrock R; Ruckhäberle E; Metzler D; Ahr A; Solbach C; Karn T; Kaufmann M
Clin Cancer Res; 2007 Feb; 13(4):1115-22. PubMed ID: 17317819
[TBL] [Abstract][Full Text] [Related]
20. The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.
Dopeso H; Mateo-Lozano S; Mazzolini R; Rodrigues P; Lagares-Tena L; Ceron J; Romero J; Esteves M; Landolfi S; Hernández-Losa J; Castaño J; Wilson AJ; Ramon y Cajal S; Mariadason JM; Schwartz S; Arango D
Cancer Res; 2009 Sep; 69(18):7430-8. PubMed ID: 19738063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]